News, Visuals and Downloads Straight From Lysando
WeltTV about Medolysin® donation to Ukraine – Positive news of the day
Behind the scenes of Lysando – introducing Artilysin®
Resistant bacteria are on the rise! Artilysin® is our solution to the global health crisis.
A world without Superbugs: Artilysin® controls bacteria – in a good way!
Lysando AG for TV
plan b (ZDF): Kampf gegen Killerkeime!
X:ENIUS – Viren als Helfer – Phagen als Therapie
Innovation Meets Compassion: Lysando and Bamberg UA Collaborate to Tackle Antibiotic Resistance in Ukrainian Hospitals with Medolysin® Donation
Lysando Welcomes Pharma Leader Dr. Holger Zimmermann to its Advisory Board
Lysando Welcomes Healthcare Visionary Jorge Cortell to its Advisory Board
Artilysin® – A Groundbreaking „Green Pharma“ Solution
Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
Yong Chul Shin, Ph.D., is Chief Scientific Officer of Lysando AG
Artilysin®: Promising approach against Acinetobacter baumannii infected wounds
Artilysin®: Fearless Into the Post-antibiotic Era
Lysando AG and Amicogen Inc. Sign General Development Agreement
Dr. Fabian Geldmacher is Director Strategy & Business Development
Wilhelm von Haller is Chief Financial Officer of Lysando AG
Lysando AG Strengthens Board of Directors by Appointment of Mr. Sang Jung Kim
AiCuris announces expansion of its collaboration with Lysando with a focus on diabetic foot infections
AMICOGEN Inc. and Lysando AG bring partnership to the next level with ownership participations in each other’s companies
Lysando AG and AMICOGEN Inc. forge a strategic partnership
Alternative to antibiotics
The search for new antibiotics
What’s next after antibiotics?
The medical sensation
Medolysin® Donation to Ukraine